Osmolytes dynamically regulate mutant Huntingtin aggregation and CREB function in Huntington's disease cell models

被引:13
|
作者
Aravindan, Shreyaas [1 ]
Chen, Samantha [1 ]
Choudhry, Hannaan [1 ]
Molfetta, Celine [1 ]
Chen, Kuang Yu [2 ]
Liu, Alice Y. C. [1 ]
机构
[1] Rutgers State Univ, Dept Cell Biol & Neurosci, Nelson Biol Lab, 604 Allison Rd, Piscataway, NJ 08854 USA
[2] Rutgers State Univ, Dept Chem & Chem Biol, Nelson Biol Lab, 604 Allison Rd, Piscataway, NJ 08854 USA
关键词
INTRINSICALLY DISORDERED PROTEINS; NEURODEGENERATIVE DISEASES; CHEMICAL CHAPERONES; ORGANIC OSMOLYTES; GENE-EXPRESSION; HSP90; CLEARANCE; MUTATIONS; STABILITY; MECHANISM;
D O I
10.1038/s41598-020-72613-3
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Osmolytes are organic solutes that change the protein folding landscape shifting the equilibrium towards the folded state. Herein, we use osmolytes to probe the structuring and aggregation of the intrinsically disordered mutant Huntingtin (mHtt) vis-a-vis the pathogenicity of mHtt on transcription factor function and cell survival. Using an inducible PC12 cell model of Huntington's disease (HD), we show that stabilizing polyol osmolytes drive the aggregation of Htt103Q(Exon1)-EGFP from a diffuse ensemble into inclusion bodies (IBs), whereas the destabilizing osmolyte urea does not. This effect of stabilizing osmolytes is innate, generic, countered by urea, and unaffected by HSP70 and HSC70 knockdown. A qualitatively similar result of osmolyte-induced mHtt IB formation is observed in a conditionally immortalized striatal neuron model of HD, and IB formation correlates with improved survival under stress. Increased expression of diffuse mHtt sequesters the CREB transcription factor to repress CREB-reporter gene activity. This repression is mitigated either by stabilizing osmolytes, which deplete diffuse mHtt or by urea, which negates protein-protein interaction. Our results show that stabilizing polyol osmolytes promote mHtt aggregation, alleviate CREB dysfunction, and promote survival under stress to support the hypothesis that lower molecular weight entities of disease protein are relevant pathogenic species in neurodegeneration.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Mutant huntingtin impairs immune cell migration in Huntington disease
    Kwan, Wanda
    Traeger, Ulrike
    Davalos, Dimitrios
    Chou, Austin
    Bouchard, Jill
    Andre, Ralph
    Miller, Aaron
    Weiss, Andreas
    Giorgini, Flaviano
    Cheah, Christine
    Moeller, Thomas
    Stella, Nephi
    Akassoglou, Katerina
    Tabrizi, Sarah J.
    Muchowski, Paul J.
    JOURNAL OF CLINICAL INVESTIGATION, 2012, 122 (12): : 4737 - 4747
  • [22] Mutant Huntingtin accumulation in the nucleus affects nucleolar function in Huntington's disease mouse models and patients at early stages
    Soenmez, A.
    Spieth, S.
    Mustafa, R.
    Kojer, K.
    Litke, C.
    Kochi, J.
    Orth, M.
    Liss, B.
    Parlato, R.
    ACTA PHYSIOLOGICA, 2019, 227
  • [23] Inhibition of Aggregation of Mutant Huntingtin by Nucleic Acid Aptamers In Vitro and in a Yeast Model of Huntington's Disease
    Chaudhary, Rajeev K.
    Patel, Kinjal A.
    Patel, Milan K.
    Joshi, Radha H.
    Roy, Ipsita
    MOLECULAR THERAPY, 2015, 23 (12) : 1912 - 1926
  • [24] Huntingtin phosphorylation and signaling pathways that regulate toxicity in Huntington's disease
    Humbert, S
    Saudou, F
    CLINICAL NEUROSCIENCE RESEARCH, 2003, 3 (03) : 149 - 155
  • [25] Parallel evaluation of mutant huntingtin and neurofilament light in Huntington's disease
    Byrne, L.
    Rodrigues, F.
    Johnson, E.
    De Vita, E.
    Czech, C.
    Schobel, S.
    Scahill, R.
    Heslegrave, A.
    Zetterberg, H.
    Wild, W.
    MOVEMENT DISORDERS, 2018, 33 : S370 - S374
  • [26] Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease
    Wellington, CL
    Ellerby, LM
    Gutekunst, CA
    Rogers, D
    Warby, S
    Graham, RK
    Loubser, O
    van Raamsdonk, J
    Singaraja, R
    Yang, YZ
    Gafni, J
    Bredesen, D
    Hersch, SM
    Leavitt, BR
    Roy, S
    Nicholson, DW
    Hayden, MR
    JOURNAL OF NEUROSCIENCE, 2002, 22 (18): : 7862 - 7872
  • [27] Development of a ligand for in vivo imaging of mutant huntingtin in Huntington's disease
    Bertoglio, Daniele
    Bard, Jonathan
    Hessmann, Manuela
    Liu, Longbin
    Gaertner, Annette
    De Lombaerde, Stef
    Huscher, Britta
    Zajicek, Franziska
    Miranda, Alan
    Peters, Finn
    Herrmann, Frank
    Schaertl, Sabine
    Vasilkovska, Tamara
    Brown, Christopher J.
    Johnson, Peter D.
    Prime, Michael E.
    Mills, Matthew R.
    Van der Linden, Annemie
    Mrzljak, Ladislav
    Khetarpal, Vinod
    Wang, Yuchuan
    Marchionini, Deanna M.
    Skinbjerg, Mette
    Verhaeghe, Jeroen
    Dominguez, Celia
    Staelens, Steven
    Munoz-Sanjuan, Ignacio
    SCIENCE TRANSLATIONAL MEDICINE, 2022, 14 (630)
  • [28] Esculetin Provides Neuroprotection against Mutant Huntingtin-Induced Toxicity in Huntington's Disease Models
    Pruccoli, Letizia
    Breda, Carlo
    Teti, Gabriella
    Falconi, Mirella
    Giorgini, Flaviano
    Tarozzi, Andrea
    PHARMACEUTICALS, 2021, 14 (10)
  • [29] Mutant huntingtin affects p53 function in a context-dependent manner in a cell model of Huntington's disease
    Ellison, Genevieve A.
    Garcia, Loren S.
    Cornett, Jonathan C.
    FASEB JOURNAL, 2018, 32 (01):
  • [30] Huntington's Disease: Function and Dysfunction of Huntingtin in Axonal Transport
    Saudou, Frederic
    Humbert, Sandrine
    INTRACELLULAR TRAFFIC AND NEURODEGENERATIVE DISORDERS, 2009, : 115 - +